FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

32661311000001102: Losartan 12.5mg tablets (Krka UK Ltd) 28 tablet 2 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-May 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2582091000001111 Losartan 12.5mg tablets (Krka UK Ltd) 28 tablet 2 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2582101000001117 Losartan 12.5mg tablets (Krka UK Ltd) 28 tablet 2 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
99765101000001111 Losartan 12.5mg tablets (Consilient Health Ltd) 28 tablet 2 x 14 tablets (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
99765201000001116 Losartan 12.5mg tablets (Consilient Health Ltd) 28 tablet 2 x 14 tablets en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Losartan 12.5mg tablets (Krka UK Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Losartan 12.5mg tablets (Krka UK Ltd) 28 tablet 2 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Losartan 12.5mg tablets (Krka UK Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Losartan 12.5mg tablets (Krka UK Ltd) 28 tablet 2 x 14 tablets Is a Losartan 12.5mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Losartan 12.5mg tablets (Krka UK Ltd) 28 tablet 2 x 14 tablets Has AMP Losartan 12.5mg tablets (Krka UK Ltd) true Inferred relationship Existential restriction modifier
Losartan 12.5mg tablets (Krka UK Ltd) 28 tablet 2 x 14 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Losartan 12.5mg tablets (Krka UK Ltd) 28 tablet 2 x 14 tablets Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Losartan 12.5mg tablets (Krka UK Ltd) 28 tablet 2 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Losartan 12.5mg tablets (Krka UK Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Losartan 12.5mg tablets (Krka UK Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient Losartan potassium true Inferred relationship Existential restriction modifier
Losartan 12.5mg tablets (Krka UK Ltd) 28 tablet 2 x 14 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Losartan 12.5mg tablets (Krka UK Ltd) 28 tablet 2 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Losartan 12.5mg tablets (Krka UK Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Losartan 12.5mg tablets (Krka UK Ltd) 28 tablet 2 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start